Logo image of BLBX

BLACKBOXSTOCKS INC (BLBX) Stock Fundamental Analysis

USA - NASDAQ:BLBX - US09229E3036 - Common Stock

10.02 USD
-2.16 (-17.73%)
Last: 10/14/2025, 9:36:04 AM
Fundamental Rating

1

Overall BLBX gets a fundamental rating of 1 out of 10. We evaluated BLBX against 282 industry peers in the Software industry. BLBX has a bad profitability rating. Also its financial health evaluation is rather negative. BLBX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BLBX has reported negative net income.
In the past year BLBX has reported a negative cash flow from operations.
In the past 5 years BLBX always reported negative net income.
BLBX had negative operating cash flow in 4 of the past 5 years.
BLBX Yearly Net Income VS EBIT VS OCF VS FCFBLBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

1.2 Ratios

BLBX has a worse Return On Assets (-38.74%) than 80.50% of its industry peers.
BLBX's Return On Equity of -106.77% is on the low side compared to the rest of the industry. BLBX is outperformed by 77.66% of its industry peers.
Industry RankSector Rank
ROA -38.74%
ROE -106.77%
ROIC N/A
ROA(3y)-66.07%
ROA(5y)-50.38%
ROE(3y)-119.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBX Yearly ROA, ROE, ROICBLBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

BLBX has a worse Gross Margin (39.37%) than 75.18% of its industry peers.
In the last couple of years the Gross Margin of BLBX has grown nicely.
BLBX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.22%
GM growth 5Y4.74%
BLBX Yearly Profit, Operating, Gross MarginsBLBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

1

2. Health

2.1 Basic Checks

BLBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLBX has more shares outstanding
BLBX has more shares outstanding than it did 5 years ago.
BLBX has a worse debt/assets ratio than last year.
BLBX Yearly Shares OutstandingBLBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
BLBX Yearly Total Debt VS Total AssetsBLBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -0.73, we must say that BLBX is in the distress zone and has some risk of bankruptcy.
BLBX has a worse Altman-Z score (-0.73) than 74.47% of its industry peers.
BLBX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
BLBX has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -0.73
ROIC/WACCN/A
WACC11.21%
BLBX Yearly LT Debt VS Equity VS FCFBLBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 0.20 indicates that BLBX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.20, BLBX is doing worse than 96.45% of the companies in the same industry.
A Quick Ratio of 0.20 indicates that BLBX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.20, BLBX is doing worse than 96.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
BLBX Yearly Current Assets VS Current LiabilitesBLBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

BLBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.01%.
BLBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.80%.
Measured over the past years, BLBX shows a quite strong growth in Revenue. The Revenue has been growing by 19.35% on average per year.
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.37%
Revenue 1Y (TTM)-17.8%
Revenue growth 3Y-25.1%
Revenue growth 5Y19.35%
Sales Q2Q%-24.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLBX Yearly Revenue VS EstimatesBLBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
BLBX Yearly EPS VS EstimatesBLBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BLBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLBX Price Earnings VS Forward Price EarningsBLBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLBX Per share dataBLBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLBX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKBOXSTOCKS INC

NASDAQ:BLBX (10/14/2025, 9:36:04 AM)

10.02

-2.16 (-17.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-12 2025-11-12
Inst Owners12.57%
Inst Owner Change0%
Ins Owners39.1%
Ins Owner Change-0.02%
Market Cap37.98M
Analysts82.86
Price TargetN/A
Short Float %1.25%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.24
P/FCF N/A
P/OCF N/A
P/B 10.59
P/tB 10.59
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.62
BVpS0.95
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.74%
ROE -106.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.37%
FCFM N/A
ROA(3y)-66.07%
ROA(5y)-50.38%
ROE(3y)-119.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.22%
GM growth 5Y4.74%
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z -0.73
F-Score2
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)118.66%
Cap/Depr(5y)131.2%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.8%
Revenue growth 3Y-25.1%
Revenue growth 5Y19.35%
Sales Q2Q%-24.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.55%
OCF growth 3YN/A
OCF growth 5YN/A